AKAN
Price
$1.37
Change
+$0.07 (+5.38%)
Updated
Jul 3 closing price
Capitalization
1.25M
INCR
Price
$1.56
Change
+$0.08 (+5.41%)
Updated
Jul 3 closing price
Capitalization
123.5M
42 days until earnings call
Interact to see
Advertisement

AKAN vs INCR

Header iconAKAN vs INCR Comparison
Open Charts AKAN vs INCRBanner chart's image
Akanda
Price$1.37
Change+$0.07 (+5.38%)
Volume$23.56K
Capitalization1.25M
Intercure
Price$1.56
Change+$0.08 (+5.41%)
Volume$25.22K
Capitalization123.5M
AKAN vs INCR Comparison Chart in %
Loading...
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKAN vs. INCR commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAN is a Hold and INCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (AKAN: $1.37 vs. INCR: $1.56)
Brand notoriety: AKAN and INCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AKAN: 54% vs. INCR: 192%
Market capitalization -- AKAN: $1.25M vs. INCR: $123.5M
AKAN [@Pharmaceuticals: Other] is valued at $1.25M. INCR’s [@Pharmaceuticals: Other] market capitalization is $123.5M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAN’s FA Score shows that 0 FA rating(s) are green whileINCR’s FA Score has 1 green FA rating(s).

  • AKAN’s FA Score: 0 green, 5 red.
  • INCR’s FA Score: 1 green, 4 red.
According to our system of comparison, INCR is a better buy in the long-term than AKAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAN’s TA Score shows that 5 TA indicator(s) are bullish while INCR’s TA Score has 3 bullish TA indicator(s).

  • AKAN’s TA Score: 5 bullish, 5 bearish.
  • INCR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AKAN is a better buy in the short-term than INCR.

Price Growth

AKAN (@Pharmaceuticals: Other) experienced а -5.52% price change this week, while INCR (@Pharmaceuticals: Other) price change was +4.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

INCR is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INCR($124M) has a higher market cap than AKAN($1.25M). INCR YTD gains are higher at: -1.887 vs. AKAN (-14.375). INCR has higher annual earnings (EBITDA): 25.8M vs. AKAN (-3.86M). INCR has more cash in the bank: 103M vs. AKAN (3.93M). AKAN has less debt than INCR: AKAN (3.83M) vs INCR (163M). INCR has higher revenues than AKAN: INCR (415M) vs AKAN (111K).
AKANINCRAKAN / INCR
Capitalization1.25M124M1%
EBITDA-3.86M25.8M-15%
Gain YTD-14.375-1.887762%
P/E RatioN/A22.52-
Revenue111K415M0%
Total Cash3.93M103M4%
Total Debt3.83M163M2%
FUNDAMENTALS RATINGS
INCR: Fundamental Ratings
INCR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKANINCR
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
85%
Momentum
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
75%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
79%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AKAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRC18.060.35
+1.98%
Tejon Ranch Co
STKH1.710.03
+1.79%
Steakholder Foods Ltd
VEEA1.750.02
+1.16%
Veea Inc
QGEN48.34-0.30
-0.62%
Qiagen N.V.
RXST13.05-0.09
-0.68%
RxSight

AKAN and

Correlation & Price change

A.I.dvisor tells us that AKAN and SCYX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKAN and SCYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKAN
1D Price
Change %
AKAN100%
+5.38%
SCYX - AKAN
30%
Poorly correlated
+1.57%
TLRY - AKAN
25%
Poorly correlated
+11.03%
CGC - AKAN
24%
Poorly correlated
+7.56%
ACB - AKAN
23%
Poorly correlated
+1.57%
CRDL - AKAN
23%
Poorly correlated
+10.79%
More

INCR and

Correlation & Price change

A.I.dvisor tells us that INCR and PHCUF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and PHCUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
+5.41%
PHCUF - INCR
26%
Poorly correlated
N/A
KMDA - INCR
24%
Poorly correlated
+1.81%
TLRY - INCR
22%
Poorly correlated
+11.03%
QNTM - INCR
22%
Poorly correlated
-10.96%
AKAN - INCR
21%
Poorly correlated
+5.38%
More